A Phase 2a Randomised, Double Blind, Multi-centre Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 Diabetes
Latest Information Update: 24 Jul 2024
Price :
$35 *
At a glance
- Drugs Mizacorat (Primary) ; Prednisolone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 18 Jun 2021 Status changed from active, no longer recruiting to completed.
- 23 Apr 2021 Planned End Date changed from 28 May 2021 to 16 Jun 2021.
- 23 Apr 2021 Planned primary completion date changed from 28 May 2021 to 16 Jun 2021.